🔴 Connect Biopharma is trading 20.62% down today amid broader risk-off conditions

Connect Biopharma is trading at $1.62, down -20.62%, amid broader risk-off conditions and weakness in smaller biotech shares.

• The Nasdaq Composite is down 1.20%, while premarket technology weakness is weighing on smaller biotech shares.
• No new company-specific announcement was identified for September 14, 2026.
• Management is scheduled to present at the H.C. Wainwright conference on September 15; H.C. Wainwright reiterated a Buy rating and $7.00 price target.